Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
This method increases bioavailability, ensuring that more of the active ingredient reaches your cells
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomized, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
PubMed El-Nahas MR, Elkannishy G, Abdelhafez H, Elkhamisy ET, El-Sehrawy AA
History of medullary thyroid cancer or MEN2 Pregnancy or breastfeeding Severe GI disorders (gastroparesis) Certain endocrine conditions Allergy to GLP-1 medications Appetite reduction begins within the first 12 weeks
Rheumatologists assess joint inflammation and musculoskeletal health, while dermatologists manage associated psoriasis symptoms for complete care
The second drug currently on the market, the tirzepatide found in Mounjaro and Zepbound, resembles GLP-1 in addition to another hormone called GIP, hitting receptors for both in the brain
US$ 27.65
US$ 23.44
US$ 23.73
US$ 28.32
US$ 23.37
US$ 20.20
US$ 28.79
US$ 26.87
US$ 28.38
US$ 25.64
US$ 26.32
